|
TMEM20 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.86210000000209E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.027610E-02 |
| Normal-vs-Stage2 |
6.336400E-02 |
| Normal-vs-Stage3 |
5.558000E-02 |
| Normal-vs-Stage4 |
4.937900E-02 |
| Stage1-vs-Stage2 |
4.694400E-01 |
| Stage1-vs-Stage3 |
1.155610E-01 |
| Stage1-vs-Stage4 |
8.682400E-02 |
| Stage2-vs-Stage3 |
1.737970E-01 |
| Stage2-vs-Stage4 |
1.202370E-01 |
| Stage3-vs-Stage4 |
7.869600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.370620E-04 |
| Normal-vs-AfricanAmerican |
9.904200E-02 |
| Normal-vs-Asian |
2.402000E-01 |
| Caucasian-vs-AfricanAmerican |
6.554000E-01 |
| Caucasian-vs-Asian |
3.817600E-01 |
| AfricanAmerican-vs-Asian |
4.128000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.388470E-02 |
| Normal-vs-Female |
3.598900E-04 |
| Male-vs-Female |
3.297400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.575600E-02 |
| Normal-vs-Extreme_Weight |
4.254000E-02 |
| Normal-vs-Obese |
2.677600E-03 |
| Normal-vs-Extreme_Obese |
9.814400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.463000E-01 |
| Normal_Weight-vs-Obese |
7.117400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.168640E-01 |
| Extreme_Weight-vs-Obese |
6.993900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.416600E-01 |
| Obese-vs-Extreme_Obese |
2.478400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.977900E-02 |
| Normal-vs-Age(41-60Yrs) |
5.71659999999419E-05 |
| Normal-vs-Age(61-80Yrs) |
4.140300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.400980E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.334400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.406000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.645900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.580700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.070370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.357800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.192300E-02 |
| Normal-VS-Type2 PRCC |
1.606270E-02 |
| Normal-VS-KIRP CIMP |
6.582200E-03 |
| Normal-VS-Unclassified PRCC |
7.022500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.286000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.980700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.942200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.637700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.473010E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.205690E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.290500E-02 |
| Normal-vs-N1 |
2.838000E-03 |
| Normal-vs-N2 |
2.939600E-01 |
| N0-vs-N1 |
1.020470E-02 |
| N0-vs-N2 |
3.681800E-01 |
| N1-vs-N2 |
9.172400E-01 |
|
|
